Italia markets close in 1 hour 21 minutes

JNJ Oct 2024 130.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,22000,0000 (0,00%)
In data: 12:00PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,2200
Aperto1,3000
Denaro0,8100
Domanda0,8900
Prezzo d'esercizio130,00
Scadenza2024-10-18
Min-Max giorno1,2200 - 1,3000
Contratto - Min-MaxN/D
Volume12
Open Interest493
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA